Latest revenue
$24.9M
as of 2026-03-31
Latest net income
$950.0K
as of 2026-03-31
Net margin
3.8%
as of 2026-03-31
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $8.4M
- Enterprise value
- $8.4M
- P/E (trailing)
- —
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- 52-wk high
- $12.45
- 52-wk low
- $3.80
- Beta
- —
- Shares out
- 1.9M
5-year trend
dashed bar = fiscal Q4 derived from 10-K annual − Q1 − Q2 − Q3 (SEC requires only three 10-Qs per year).
What this company does
Item 1. Business Overview Mannatech, Incorporated ("Mannatech" or the "Company") is a global wellness solution provider, which was incorporated and began operations in November 1993. We develop and sell innovative, high quality, proprietary nutritional supplements, skin care and anti-aging products, and weight-management products that target optimal health and wellness. We currently sell our products in three regions: (i) the Americas (the United States, Canada and Mexico); (ii) Europe/the Middle East/Africa (“EMEA”) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden and the United…
AI summary unavailable — showing raw filing excerpt
Generated from MTEX's filing dated 2026-04-15
Key risks
Item 1A. Risk Factors In addition to the other risks described in this report, the risk factors outlined below should be considered in evaluating our business and future prospects. Several of the risks are part of conducting business in the industry and sales channel in which we operate and will likely remain ongoing. The fact that these risks are characteristic of the dietary supplement industry or the direct selling channel does not lessen their significance. The risks outlined below are not the only risks we may encounter. Additional risks not currently known to us or that may currently reasonably seem immaterial also may have an adverse effect on our business. Risks Affecting Our…
AI summary unavailable — showing raw filing excerpt
Generated from MTEX's filing dated 2026-04-15
Profitability
Gross margin
74.9%
3.4%Operating margin
-0.4%
132.5%Net margin
-14.1%
766.5%Return on equity
-176.6%
711.0%Return on assets
-50.7%
834.5%Leverage
Debt / equity
2.48×
22.1%Long-term debt / equity
0.32×
5.2%Debt / assets
71.3%
6.3%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | $24.9M | -6.2% | $950.0K | +162.1% | 3.8% |
Q3 2025 2025-09-30 | $29.2M | -8.1% | $1.9M | +743.9% | 6.6% |
Q1 2025 2025-03-31 | $26.6M | -9.6% | $-1.5M | -229.7% | -5.8% |
Q4 2024 2024-12-31 | $29.0M | — | $526.0K | — | 1.8% |
Q3 2024 2024-09-30 | $31.7M | -2.5% | $228.0K | +1166.7% | 0.7% |
Q2 2024 2024-06-30 | $27.7M | -14.9% | $556.0K | +211.0% | 2.0% |
Q1 2024 2024-03-31 | $29.4M | — | $1.2M | — | 4.0% |
Q3 2023 2023-09-30 | $32.6M | — | $18.0K | — | 0.1% |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Medicinal Chemicals & Botanical Products · SIC 2833
Your notes
Keep private notes on MTEX — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$62.2K
Insider selling
$0
Net activity
+$62.2K
Distinct insiders
2
Open-market trades over the last 365 days.
Recent transactions
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns MTEX
Institutional value
$691.3K
Total shares held
124.9K
Distinct holders
10
-9 vs prior
As of
2026-03-31
Prior: 2025-12-31
Filers with $100M+ AUM disclose holdings 45 days after quarter end.
Top institutional holders
| # | Manager | Shares | Value | QoQ change | Action |
|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 52.2K | $301.5K | +0 (+0.0%) | No change |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 49.6K | $297.7K | — | New |
| 3 | DIMENSIONAL FUND ADVISORS LP | 11.9K | $71.5K | -753 (-5.9%) | Trimmed |
| 4 | VANGUARD FIDUCIARY TRUST CO | 2.7K | $16.1K | — | New |
| 5 | UBS Group AG | 485 | $2.8K | +6 (+1.3%) | Added |
| 6 | Vanguard Global Advisers, LLC | 250 | $1.5K | — | New |
| 7 | SRS Capital Advisors, Inc. | 12 | $72 | +0 (+0.0%) | No change |
| 8 | ACADIAN ASSET MANAGEMENT LLC | 7.7K | $46 | +0 (+0.0%) | No change |
| 9 | SBI Securities Co., Ltd. | 1 | $6 | -1 (-50.0%) | Trimmed |
| 10 | WELLS FARGO & COMPANY/MN | 1 | $4 | -1 (-50.0%) | Trimmed |
Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.
Top questions investors are asking
Coming once MTEX's latest filing finishes processing.